LIPOCINE INC. Increase (Decrease) in Due to Officers and Stockholders
LIPOCINE INC. (LPCN) reported Increase (Decrease) in Due to Officers and Stockholders of $238 for the 21-month period ending 2013-06-30, per its 10-Q filed 2013-07-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToOfficersAndStockholders · last filed 2013-07-09
- LIPOCINE INC. increase (decrease) in due to officers and stockholders for the quarter ending 2013-06-30 was $0.00.
- LIPOCINE INC. increase (decrease) in due to officers and stockholders for the quarter ending 2013-03-31 was $0.00.
- LIPOCINE INC. increase (decrease) in due to officers and stockholders for the quarter ending 2012-12-31 was $0.00, a 100.00% decline year-over-year.
- LIPOCINE INC. increase (decrease) in due to officers and stockholders for the quarter ending 2011-12-31 was $238.00.
- LIPOCINE INC. increase (decrease) in due to officers and stockholders for fiscal 2011 was $238.00.
| Period end | Increase (Decrease) in Due to Officers and Stockholders 3 month | Increase (Decrease) in Due to Officers and Stockholders 6 month | Increase (Decrease) in Due to Officers and Stockholders 9 month | Increase (Decrease) in Due to Officers and Stockholders 12 month | Increase (Decrease) in Due to Officers and Stockholders 15 month | Increase (Decrease) in Due to Officers and Stockholders 18 month | Increase (Decrease) in Due to Officers and Stockholders 21 month |
|---|---|---|---|---|---|---|---|
| 2013-06-30 | $0.00 derived: 10-Q 21 month − 10-Q 18 month · filed 2013-07-09 | $0.00 derived: sum of 2 quarters · filed 2013-07-09 | $0.00 derived: sum of 3 quarters · filed 2013-07-09 | $238.00 10-Q · filed 2013-07-09 | |||
| 2013-03-31 | $0.00 derived: 10-Q 18 month − 10-K 15 month · filed 2013-04-24 | $0.00 derived: sum of 2 quarters · filed 2013-04-24 | $238.00 10-Q · filed 2013-04-24 | ||||
| 2012-12-31 | $0.00 derived: 10-K 15 month − 10-Q 12 month · filed 2013-02-26 | $238.00 10-K · filed 2013-02-26 | |||||
| 2012-09-30 | $0.00 10-Q · filed 2012-10-26 | $238.00 10-Q · filed 2012-10-26 | |||||
| 2011-12-31 | $238.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $238.00 10-K · filed 2013-02-26 | |||||
| 2011-09-30 | $0.00 10-Q · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |